查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1988393

管腔成形术市场：2026-2032年全球市场预测（依产品类型、手术方法、最终用户、通路、适应症和年龄层划分）

Canaloplasty Market by Product Type, Technique, End User, Distribution Channel, Indication, Age Group - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，导管成形术市场价值将达到 5.9484 亿美元，到 2026 年将成长至 6.4248 亿美元，到 2032 年将达到 9.8748 亿美元，年复合成长率为 7.50%。

主要市场统计数据
基准年 2025 5.9484亿美元
预计年份：2026年 6.4248亿美元
预测年份 2032 9.8748亿美元
复合年增长率 (%) 7.50%

从临床和商业性角度概述了管腔成形术，将其定位为一个程序生态系统，它透过设备、技术和临床环境重塑了青光眼治疗的交付方式。

在手术技术创新和临床医师日益深入的理解推动下，小梁成形术正逐渐成为青光眼治疗新典范的核心。该领域结合了精密的显微外科技术和基于器械的治疗方法，旨在恢復房水生理性流出，同时减少对长期药物治疗的依赖。因此，临床医生和医疗系统越来越认识到，小梁成形术是传统滤过手术和现代微创手术之间的桥樑。

器材工程的平行进步、微创技术的引入以及医疗保健服务体系的重新设计，正在重新定义管腔成形术的临床实践和商业化。

近年来，技术进步、流程标准化和相关人员的协作共同创造了新的机会，带来了变革性的改变，重新定义了管腔成形术的实施和商业化方式。微导管设计的创新提高了管腔内导航和扩张的准确性，而手术器械包中越来越多地配备了优化的黏弹性物质，这些物质能够提供可预测的组织行为，并促进可重复的治疗效果。除了这些产品层面的进步之外，人们越来越倾向于采用「内路」（Ab Interno）技术，这是一种微创技术，它透过减少手术创伤、加快康復速度和降低资源消耗，扩大了适用人群。

评估近期美国关税调整如何重塑 Kanaloplastics 利害关係人的供应链选择、製造策略和商业性动态。

美国2025年实施的关税政策，对服务于眼科医疗设备製造商和经销商的全球供应链产生了连锁反应，带来了新的限制和奖励。针对特定医疗设备和组件进口关税的调整，迫使製造商加快重新评估筹资策略，重新评估区域製造地，并实现供应商多元化，以降低成本风险。因此，这些变化正在影响分销商的定价策略，以及原始设备製造商（OEM）分销商和增值转售商之间的谈判动态。这些经销商必须在维持服务水准的同时，应对利润率压力。

策略性细分洞察揭示了产品类型、外科手术程序、最终用户环境、通路、临床适应症和年龄层如何相互作用，从而决定临床采用和商业性重点。

透过详细的细分观点，可以揭示哪些产品类型和手术方法会影响临床医生的偏好和购买行为。微导管的产品创新提高了管腔内导航和输送精度，而整合式手术套件的普及则简化了术中工作流程并减少了设定差异。黏弹性剂在管腔成形术中发挥至关重要的作用，而黏性黏弹性剂和分散性黏弹性剂之间的差异具有重要的临床意义。黏性黏弹性剂有助于在一次手术中完成管腔扩张和取出，而分散性配方可能在复杂的解剖结构中提供更好的组织保护，这会影响临床医生根据具体病例情况的选择。

区域比较评估，以确定报销制度、临床基础设施和分销生态系统对管腔成形术的推广和供应商策略影响最大的区域。

区域趋势差异显着，投资、临床教育和供应链优化等因素影响哪些地区取得最佳成果。在美洲，成熟的报销体系和完善的门诊手术基础设施支援微创管成形术的快速普及；然而，该地区也面临着集中的成本压力，促使采购趋势转向捆绑式解决方案和经济实惠的耗材。欧洲、中东和非洲（EMEA）地区的情况则较为复杂。一些欧洲市场拥有先进的监管路径和广泛的手术应用，而中东和非洲则涌现出许多新兴的优秀医疗中心，这些中心优先开展旨在提升当地医疗能力的培训和技术转移计画。在这些地区，与当地分销商建立合作关係以及投资于临床医生教育对于扩大手术量至关重要。

竞争与伙伴关係模式是卡纳洛塑胶公司发展壮大的关键，这些公司包括成熟的多元化投资组合公司、创新专家和通路合作伙伴。

竞争格局呈现出两极化的局面：既有拥有广泛眼科产品线的成熟医疗设备製造商，也有专注于微创青光眼手术技术的专业创新企业。老字型大小企业利用临床试验网路、手术训练计画和一体化服务模式，维护高价值基本客群，并将自身定位为提供全面手术解决方案的供应商。同时，专业医疗设备公司则专注于差异化的导管设计、一次性手术包或新型黏弹剂，从而获得临床实践的支持，并在早期用户中确立高端地位。

为了加快推广应用，製造商和通路合作伙伴应专注于以下几个方面：收集证据、开发适应性强的商业模式以及设计具有韧性的供应链。

产业领导者应优先考虑以下三个面向：产生临床证据、增强供应链韧性以及开发差异化的商业模式，以维持发展动能。投资于前瞻性註册研究和合作性真实世界证据（RWE）计画将有助于检验针对不同适应症的治疗效果，包括原发性开放性青光眼以及新生血管性和色素性等疑难续发性青光眼。这些努力应与有针对性的临床医生教育倡议相结合，重点强调外路和内路手术方法之间的细微操作差异，以及选择黏弹性物质（黏性剂和分散性剂）的实际意义。

本研究结合了主要调查方法（说明对临床医生和相关人员的访谈）和次要研究方法（例如对监管和临床文献的审查以及多轴分割分析）。

本分析的调查方法结合了定性和定量方法，旨在深入了解小梁成形术的发展趋势。主要调查包括对青光眼外科医生、门诊手术中心管理人员、医院采购负责人和销售合作伙伴进行结构化访谈，以收集第一线人员对手术方案选择、器械偏好和服务期望的观点。此外，我们还进行了补充调查，整合了监管指南、手术规范框架和已发表的临床文献，以全面检验临床应用的驱动因素，并识别不同器械之间的比较特征。

强调证据、培训和营运韧性的策略整合，对于将管腔成形术的临床创新转化为永续的临床应用至关重要。

总之，管腔成形术处于医疗设备创新、外科技术发展和医疗服务模式变革的交汇点，所有这些因素共同对製造商、分销商和医疗机构产生了重大的策略影响。在此背景下，能够将可靠的临床证据、临床医生培训和灵活的销售管道相结合，同时保持供应链的适应性并应对不断变化的贸易政策和区域监管复杂性的企业将拥有显着优势。产品差异化，尤其是在微导管性能、手术器械包设计和黏弹性方面，将继续影响临床医生的选择和手术技术的应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：管腔成形术市场：依产品类型划分

  • 微导管
  • 手术包
  • 黏弹性剂
    • 内聚黏弹性剂
    • 可分散黏弹性剂

第九章：根管成形术市场：依手术方法划分

  • 外眼入路
  • 内眼方法
    • 微创方法

第十章：导管成形术市场：依最终用户划分

  • 门诊手术中心
    • 合作伙伴设施
    • 独立设施
  • 医院
    • 私立医院
    • 公立医院
  • 眼科诊所
    • 连锁诊所
    • 独立诊所

第十一章：导管成形术市场：依通路划分

  • 直销
  • 透过分销商销售
    • OEM分销商
    • 增值转售商

第十二章 耳蜗成形术市场：依适应症划分

  • 原发性开放性青光眼
  • 续发性青光眼
    • 新生血管性青光眼
    • 色素性青光眼

第十三章：耳道成形术市场：依年龄组别划分

  • 成人
  • 老年人
  • 儿童

第十四章：导管成形术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：管腔成形术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：管腔成形术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 美国：管腔成形术市场

第十八章 中国：管腔成形术市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alcon Inc.
  • Beaver-Visitec International
  • Glaukos Corporation
  • InnFocus Inc.
  • iSTAR Medical SA
  • Ivantis Inc.
  • Johnson & Johnson Vision
  • New World Medical Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sight Sciences Inc.
  • SOLX Inc.
Product Code: MRR-8958E923A70E

The Canaloplasty Market was valued at USD 594.84 million in 2025 and is projected to grow to USD 642.48 million in 2026, with a CAGR of 7.50%, reaching USD 987.48 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 594.84 million
Estimated Year [2026] USD 642.48 million
Forecast Year [2032] USD 987.48 million
CAGR (%) 7.50%

A clinical and commercial overview that positions canaloplasty as a procedural ecosystem reshaping glaucoma care delivery across devices, techniques, and care settings

Canaloplasty has emerged as a focal point in the evolving treatment paradigm for glaucoma, driven by procedural innovation and expanding clinician familiarity. The field blends refined micro-surgical techniques with device-enabled approaches that aim to restore physiologic aqueous outflow while reducing reliance on chronic pharmacotherapy. As a result, clinicians and health systems are increasingly exploring canaloplasty as a bridge between traditional filtration surgeries and modern microinvasive options.

This introduction frames canaloplasty not simply as a procedure, but as an ecosystem comprising specialized instruments such as microcatheters, integrated surgical kits, and supporting viscoelastic agents designed to facilitate trabecular and Schlemm's canal interventions. The technique portfolio spans Ab Externo approaches to Ab Interno microinvasive procedures, and the treatment is being adopted across care settings from ambulatory surgical centers to hospital operating theaters and dedicated ophthalmology clinics. Understanding these dynamics is essential for stakeholders seeking to prioritize product roadmaps, refine commercial models, and align clinical evidence generation with payer and provider expectations.

How concurrent advances in device engineering, microinvasive technique adoption, and care delivery redesign are converging to redefine canaloplasty practice and commercialization

Recent years have witnessed transformative shifts that are redefining how canaloplasty is practiced and commercialized, with technological refinement, procedural standardization, and stakeholder alignment converging to create new opportunities. Innovation in microcatheter design has improved navigation and dilation of the canal, while surgical kits are increasingly bundled with optimized viscoelastic agents that deliver predictable tissue behavior and facilitate reproducible outcomes. These product-level advances are complemented by a shift toward Ab Interno microinvasive approaches that reduce surgical trauma and expand the candidate pool by enabling faster recovery and lower resource utilization.

Concurrently, payer perceptions and hospital credentialing practices are evolving. Real-world evidence demonstrating the potential to reduce medication burden and improve intraocular pressure stability has supported more streamlined coverage pathways in certain jurisdictions. Additionally, care delivery is shifting toward ambulatory surgical centers and specialized ophthalmology clinics that can perform high volumes of minimally invasive procedures. These centers are investing in training, device inventories, and protocol standardization, accelerating diffusion and creating a competitive environment in which suppliers must demonstrate both clinical value and operational efficiency.

Assessment of how recent United States tariff adjustments have reshaped supply chain choices, manufacturing strategies, and commercial dynamics for canaloplasty stakeholders

The tariffs implemented by the United States in 2025 introduced a new set of constraints and incentives that ripple across global supply chains serving ophthalmic device manufacturers and distributors. Tariff adjustments on certain medical devices and component imports have compelled manufacturers to reassess sourcing strategies, reconsider regional manufacturing footprints, and accelerate supplier diversification to mitigate cost exposure. In turn, these shifts have influenced distributor pricing strategies and the negotiation dynamics between Original Equipment Distributors and value added resellers, who must manage margin pressure while preserving service levels.

Beyond procurement, the tariff environment affected investment timing and capital allocation decisions. Some established manufacturers accelerated local assembly or sought contractual toll-manufacturing arrangements within tariff-favored jurisdictions to preserve competitiveness. Conversely, smaller specialized device firms faced tighter windows to absorb incremental cost without compromising commercial momentum, prompting some to prioritize high-value product lines and strategic partnerships. As a result, clinicians and institutional purchasers observed subtle shifts in product availability, promotional support, and post-market service offerings, reinforcing the importance of resilient supply chain design and adaptive commercial models in the face of trade policy volatility.

Strategic segmentation insights revealing how product types, procedural techniques, end-user settings, distribution routes, clinical indications, and age cohorts jointly determine clinical adoption and commercial focus

A granular segmentation lens reveals which product categories and procedural approaches are shaping clinician preference and purchasing behavior. Product innovations in microcatheters have improved canal navigation and delivery precision, while the proliferation of integrated surgical kits streamlines intraoperative workflows and reduces setup variability. Viscoelastic agents play a crucial role in canaloplasty procedures, and distinctions between cohesive viscoelastics and dispersive viscoelastics matter clinically; cohesive agents facilitate canal expansion and removal in a single sweep, whereas dispersive formulations may confer more tissue protection in complex anatomy, influencing clinician choice depending on the case profile.

Technique segmentation further differentiates market needs. Ab Externo approaches remain relevant for certain anatomies and surgeon preferences, but the rapid ascent of Ab Interno techniques-especially those leveraging microinvasive approaches-has broadened adoption among anterior segment surgeons who favor reduced invasiveness and faster postoperative recovery. End-user segmentation underlines where procedural adoption surfaces in the healthcare delivery chain: ambulatory surgical centers, both affiliated and independent, are key venues for high-throughput minimally invasive procedures; hospitals, whether private or public, continue to support more complex cases and training; and ophthalmology clinics, including chain networks and independent practices, are increasingly integrating procedural offerings alongside clinical management. Distribution channel dynamics are similarly nuanced. Direct sales remain critical for high-touch, capital-intensive accounts that require training and clinical support, whereas distributor sales, routed through original equipment distributors or value added resellers, enable broader geographic reach and flexible inventory management. Clinical indications also shape clinical pathways and procurement priorities. Primary open angle glaucoma remains the predominant indication driving procedural volume, while secondary glaucomas, such as neovascular and pigmentary glaucoma, create demand for tailored approaches and adjunctive products. Finally, age group segmentation underscores distinct clinical considerations across adult, geriatric, and pediatric patients, with geriatric cohorts presenting comorbidity patterns that influence perioperative planning and device selection.

Comparative regional evaluation that clarifies where reimbursement frameworks, clinical infrastructure, and distribution ecosystems most strongly influence canaloplasty adoption and supplier strategy

Regional dynamics vary significantly and influence where investment, clinical education, and supply chain optimization yield the greatest returns. In the Americas, mature reimbursement frameworks and established ambulatory surgical infrastructure support rapid adoption of minimally invasive canaloplasty options, yet this region also faces concentrated cost pressures that shift purchasing toward bundled solutions and cost-effective consumables. Europe, Middle East & Africa presents a heterogeneous landscape: select European markets exhibit advanced regulatory pathways and broad procedural uptake, while pockets across the Middle East and Africa show emerging centers of excellence that prioritize training and technology transfer programs to build local capacity. In these geographies, partnerships with local distributors and investment in clinician education are pivotal to scaling procedural volumes.

Asia-Pacific spans highly developed markets with sophisticated hospital systems and rapidly expanding ambulatory networks, as well as emerging economies where access to specialty devices is improving. In well-resourced APAC markets, there is a premium on innovation and evidence generation to support differentiated product positioning, whereas in growth markets, affordability and supply chain reliability drive procurement. Across regions, regulatory nuances, reimbursement mechanisms, and the distribution ecosystem shape timing and pathways for clinical adoption. As a consequence, a region-aware commercial playbook that aligns product configurations, training investments, and distributor engagement strategies is essential to capture opportunity while managing operational risk.

Competitive dynamics and partnership models that distinguish established multi-portfolio firms, specialized innovators, and channel partners driving adoption and scale in canaloplasty

The competitive landscape is characterized by a mix of established medical device firms with broad ophthalmic portfolios and focused innovators that specialize in microinvasive glaucoma surgery technologies. Established players leverage clinical trial networks, surgeon training programs, and integrated service models to protect high-value accounts and to position comprehensive procedural solutions. Focused device firms, on the other hand, concentrate on differentiated catheter designs, single-use surgical kits, or novel viscoelastic chemistries to gain clinical traction and to command premium positioning among early adopters.

Complementing these manufacturers, contract manufacturers and high-quality component suppliers play an instrumental role in bringing complex microdevice designs to market quickly and at scale. Similarly, distributor partners, whether original equipment distributors or value added resellers, contribute localized market knowledge, aftermarket service, and channel flexibility. Strategic collaborations between technology owners and distribution partners are increasingly common, enabling rapid geographic expansion while reducing direct operating burden. Finally, service-oriented entrants that bundle training, outcomes tracking, and procedural support are differentiating by promising faster adoption cycles and better real-world outcomes documentation, thereby appealing to health systems prioritizing clinical governance and quality assurance.

Actionable strategic priorities for manufacturers and channel partners focused on evidence generation, adaptive commercial models, and resilient supply chain design to accelerate adoption

Industry leaders should prioritize a combination of clinical evidence generation, supply chain resilience, and differentiated commercial models to sustain momentum. Investing in prospective registries and collaborative real-world evidence programs will help validate outcomes across diverse indications, including primary open angle glaucoma and challenging secondary glaucomas such as neovascular and pigmentary etiologies. These efforts should be synchronized with targeted clinician education initiatives that emphasize technique nuances between Ab Externo and Ab Interno approaches and the practical implications of choosing cohesive versus dispersive viscoelastic agents.

On the commercial front, organizations would benefit from tailoring engagement models to end-user segmentation. High-touch accounts in hospital systems and affiliated ambulatory surgical centers often require direct sales engagement, hands-on training, and bundled service arrangements, whereas broader geographic coverage can be achieved through distributor sales that leverage original equipment distributors and value added resellers. Operationally, companies should diversify manufacturing and component sourcing to mitigate tariff and trade risks, while exploring nearshoring or regional assembly strategies that preserve margin and delivery reliability. Finally, aligning product roadmaps with age-specific clinical needs and with the procedural preferences of high-volume surgeons will strengthen reimbursement dialogues and differentiate offerings in competitive tenders.

Methodological framework describing primary clinician and stakeholder interviews complemented by secondary regulatory and clinical literature reviews with multi-axis segmentation analysis

The research methodology underpinning this analysis combined qualitative and quantitative approaches to construct a robust understanding of canaloplasty dynamics. Primary research included structured interviews with practicing glaucoma surgeons, ambulatory surgical center administrators, hospital procurement officers, and distributor partners to capture firsthand perspectives on procedure selection, device preferences, and service expectations. These interviews were complemented by secondary research that synthesized regulatory guidance, procedural coding frameworks, and published clinical literature to triangulate clinical adoption drivers and to verify comparative device attributes.

Analytical frameworks used in the study emphasized segmentation across product types, techniques, end-user settings, distribution channels, clinical indications, and patient age groups to surface actionable insights. Supply chain and policy impact analysis incorporated trade policy review, procurement practices, and supplier capability assessments. Where applicable, sensitivity checks and cross-validation against clinician feedback ensured that conclusions reflect operational realities and the practical constraints encountered by adopters in diverse geographies.

A strategic synthesis emphasizing the imperative for evidence, training, and operational resilience to convert clinical innovation in canaloplasty into sustained clinical adoption

In summary, canaloplasty represents an intersection of device innovation, procedural evolution, and shifting care delivery models that together create substantial strategic implications for manufacturers, distributors, and clinical institutions. The landscape favors organizations that can combine robust clinical evidence, clinician training, and flexible commercial channels while maintaining supply chain adaptability in the face of trade policy changes and regional regulatory complexity. Attention to product differentiation-particularly in microcatheter performance, surgical kit design, and viscoelastic properties-will continue to influence clinician preference and procedural uptake.

Moving forward, stakeholders that invest in partnership models, targeted real-world evidence programs, and regionally optimized go-to-market strategies will be best positioned to translate clinical promise into enduring adoption. Coordinated efforts that align innovation, reimbursement engagement, and operational resilience will be essential to meet the nuanced needs of diverse patient cohorts and care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Canaloplasty Market, by Product Type

  • 8.1. Microcatheters
  • 8.2. Surgical Kits
  • 8.3. Viscoelastic Agents
    • 8.3.1. Cohesive Viscoelastic
    • 8.3.2. Dispersive Viscoelastic

9. Canaloplasty Market, by Technique

  • 9.1. Ab Externo
  • 9.2. Ab Interno
    • 9.2.1. Microinvasive Approach

10. Canaloplasty Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Affiliated Centers
    • 10.1.2. Independent Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Ophthalmology Clinics
    • 10.3.1. Chain Clinics
    • 10.3.2. Independent Clinics

11. Canaloplasty Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
    • 11.2.1. Original Equipment Distributors
    • 11.2.2. Value Added Resellers

12. Canaloplasty Market, by Indication

  • 12.1. Primary Open Angle Glaucoma
  • 12.2. Secondary Glaucoma
    • 12.2.1. Neovascular Glaucoma
    • 12.2.2. Pigmentary Glaucoma

13. Canaloplasty Market, by Age Group

  • 13.1. Adult
  • 13.2. Geriatric
  • 13.3. Pediatric

14. Canaloplasty Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Canaloplasty Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Canaloplasty Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Canaloplasty Market

18. China Canaloplasty Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alcon Inc.
  • 19.6. Beaver-Visitec International
  • 19.7. Glaukos Corporation
  • 19.8. InnFocus Inc.
  • 19.9. iSTAR Medical SA
  • 19.10. Ivantis Inc.
  • 19.11. Johnson & Johnson Vision
  • 19.12. New World Medical Inc.
  • 19.13. Santen Pharmaceutical Co. Ltd.
  • 19.14. Sight Sciences Inc.
  • 19.15. SOLX Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CANALOPLASTY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CANALOPLASTY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CANALOPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL CANALOPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GCC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 232. GCC CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GCC CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GCC CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 238. GCC CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 239. GCC CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 240. GCC CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. G7 CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. G7 CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 272. G7 CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 274. G7 CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. G7 CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. G7 CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 280. G7 CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 281. G7 CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 282. G7 CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. NATO CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. NATO CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 286. NATO CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 287. NATO CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 288. NATO CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 291. NATO CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. NATO CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 294. NATO CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 295. NATO CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 296. NATO CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)